Cargando…
Painless thyroiditis in a dupilumab-treated patient
SUMMARY: Dupilumab an inhibitor of the interleukin (IL)-4R-alpha subunit is used for the treatment of allergic diseases. The patient was a 49-year-old man who received dupilumab for the treatment of severe atopic dermatitis. He presented hyperthyroidism with elevated thyroglobulin and anti-thyroid a...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354710/ https://www.ncbi.nlm.nih.gov/pubmed/32554823 http://dx.doi.org/10.1530/EDM-20-0030 |
_version_ | 1783558146632974336 |
---|---|
author | Narantsatsral, Daramjav Junko, Takagi Hideyuki, Iwayama Daisuke, Inukai Hiroyuki, Takama Yuka, Nomura Syo, Hirase Hiroyuki, Morita Kazuo, Otake Tetsuya, Ogawa Akiyoshi, Takami |
author_facet | Narantsatsral, Daramjav Junko, Takagi Hideyuki, Iwayama Daisuke, Inukai Hiroyuki, Takama Yuka, Nomura Syo, Hirase Hiroyuki, Morita Kazuo, Otake Tetsuya, Ogawa Akiyoshi, Takami |
author_sort | Narantsatsral, Daramjav |
collection | PubMed |
description | SUMMARY: Dupilumab an inhibitor of the interleukin (IL)-4R-alpha subunit is used for the treatment of allergic diseases. The patient was a 49-year-old man who received dupilumab for the treatment of severe atopic dermatitis. He presented hyperthyroidism with elevated thyroglobulin and anti-thyroid antibody negativity at 4 months after the initiation of therapy. On scintigraphy, the thyroid radioiodine uptake was low. Ultrasonography showed a diffuse hypoechoic area in the thyroid gland. A pathological study revealed lymphocytic infiltration. The administration of dupilumab was continued because of his atopic dermatitis that showed an excellent response. The patient`s hyperthyroidism changed to hypothyroidism 3 weeks later. Six months later his thyroid function normalized without any treatment. We herein describe the case of a patient with atopic dermatitis who developed painless thyroiditis under treatment with dupilumab. To the best of our knowledge, this is the first report of this event in the literature. LEARNING POINTS: Dupilumab, a fully human monoclonal antibody that blocks interleukin-4 and interleukin-13, has been shown to be effective in the treatment atopic dermatitis and asthma with eosinophilia. Painless thyroiditis is characterized by transient hyperthyroidism and hypothyroidism and recovery without anti-thyroid treatment. This is the first report of painless thyroiditis as an adverse effect of dupilumab, although conjunctivitis and nasopharyngitis are the main adverse effects of dupilumab. |
format | Online Article Text |
id | pubmed-7354710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-73547102020-07-15 Painless thyroiditis in a dupilumab-treated patient Narantsatsral, Daramjav Junko, Takagi Hideyuki, Iwayama Daisuke, Inukai Hiroyuki, Takama Yuka, Nomura Syo, Hirase Hiroyuki, Morita Kazuo, Otake Tetsuya, Ogawa Akiyoshi, Takami Endocrinol Diabetes Metab Case Rep Unusual Effects of Medical Treatment SUMMARY: Dupilumab an inhibitor of the interleukin (IL)-4R-alpha subunit is used for the treatment of allergic diseases. The patient was a 49-year-old man who received dupilumab for the treatment of severe atopic dermatitis. He presented hyperthyroidism with elevated thyroglobulin and anti-thyroid antibody negativity at 4 months after the initiation of therapy. On scintigraphy, the thyroid radioiodine uptake was low. Ultrasonography showed a diffuse hypoechoic area in the thyroid gland. A pathological study revealed lymphocytic infiltration. The administration of dupilumab was continued because of his atopic dermatitis that showed an excellent response. The patient`s hyperthyroidism changed to hypothyroidism 3 weeks later. Six months later his thyroid function normalized without any treatment. We herein describe the case of a patient with atopic dermatitis who developed painless thyroiditis under treatment with dupilumab. To the best of our knowledge, this is the first report of this event in the literature. LEARNING POINTS: Dupilumab, a fully human monoclonal antibody that blocks interleukin-4 and interleukin-13, has been shown to be effective in the treatment atopic dermatitis and asthma with eosinophilia. Painless thyroiditis is characterized by transient hyperthyroidism and hypothyroidism and recovery without anti-thyroid treatment. This is the first report of painless thyroiditis as an adverse effect of dupilumab, although conjunctivitis and nasopharyngitis are the main adverse effects of dupilumab. Bioscientifica Ltd 2020-06-16 /pmc/articles/PMC7354710/ /pubmed/32554823 http://dx.doi.org/10.1530/EDM-20-0030 Text en © 2020 The authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. (http://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Unusual Effects of Medical Treatment Narantsatsral, Daramjav Junko, Takagi Hideyuki, Iwayama Daisuke, Inukai Hiroyuki, Takama Yuka, Nomura Syo, Hirase Hiroyuki, Morita Kazuo, Otake Tetsuya, Ogawa Akiyoshi, Takami Painless thyroiditis in a dupilumab-treated patient |
title | Painless thyroiditis in a dupilumab-treated patient |
title_full | Painless thyroiditis in a dupilumab-treated patient |
title_fullStr | Painless thyroiditis in a dupilumab-treated patient |
title_full_unstemmed | Painless thyroiditis in a dupilumab-treated patient |
title_short | Painless thyroiditis in a dupilumab-treated patient |
title_sort | painless thyroiditis in a dupilumab-treated patient |
topic | Unusual Effects of Medical Treatment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354710/ https://www.ncbi.nlm.nih.gov/pubmed/32554823 http://dx.doi.org/10.1530/EDM-20-0030 |
work_keys_str_mv | AT narantsatsraldaramjav painlessthyroiditisinadupilumabtreatedpatient AT junkotakagi painlessthyroiditisinadupilumabtreatedpatient AT hideyukiiwayama painlessthyroiditisinadupilumabtreatedpatient AT daisukeinukai painlessthyroiditisinadupilumabtreatedpatient AT hiroyukitakama painlessthyroiditisinadupilumabtreatedpatient AT yukanomura painlessthyroiditisinadupilumabtreatedpatient AT syohirase painlessthyroiditisinadupilumabtreatedpatient AT hiroyukimorita painlessthyroiditisinadupilumabtreatedpatient AT kazuootake painlessthyroiditisinadupilumabtreatedpatient AT tetsuyaogawa painlessthyroiditisinadupilumabtreatedpatient AT akiyoshitakami painlessthyroiditisinadupilumabtreatedpatient |